| 
			
			 It is the first settlement to result from a wave of recent lawsuits 
			over the drugmaker's marketing of painkillers. 
 The settlement with Oklahoma Attorney General Mike Hunter came just 
			weeks before Purdue, owned by members of the wealthy Sackler family, 
			was set to face the first trial to result from around 2,000 lawsuits 
			nationally against opioid manufacturers.
 
 Hunter's 2017 lawsuit accuses Purdue, Johnson & Johnson & Teva 
			Pharmaceutical Industries Ltd of engaging in deceptive marketing 
			that downplayed the risks of addiction associated with opioid pain 
			drugs while overstating their benefits.
 
			
			 
			
 The companies deny wrongdoing. They had sought to delay the May 28 
			trial to Sept. 16, citing the need to review records the state 
			belatedly turned over that could be critical to their defense. The 
			state had been seeking over $20 billion in damages.
 
 But a trial judge earlier this month rejected the companies' efforts 
			to delay the trial, and on Monday, Oklahoma's Supreme Court rejected 
			their appeal of that decision.
 
 Stamford, Connecticut-based Purdue had been exploring filing for 
			Chapter 11 bankruptcy protection to address potential liabilities 
			stemming from the lawsuits, people familiar with the matter have 
			told Reuters.
 
			Hunter is scheduled to hold a press conference on Tuesday to 
			announce a "breaking development" in the lawsuit. A spokesman for 
			Hunter declined to comment. A lawyer for Purdue did not respond to a 
			request for comment. 
			
            [to top of second column] | 
            
			 
			Opioids, including prescription painkillers, heroin and fentanyl, 
			were involved in a record 47,600 overdose deaths in 2017 in the 
			United States, according to the U.S. Centers for Disease Control and 
			Prevention. 
			The epidemic has prompted lawsuits by state and local governments 
			accusing various drugmakers of contributing to the crisis. Those 
			companies include Purdue, which introduced the painkiller OxyContin 
			to the market in 1996.
 More than 1,600 lawsuits have been consolidated before a federal 
			judge in Ohio, who has pushed for a settlement ahead of the trial 
			before him in October. Other cases, including Oklahoma's, are 
			pending in state courts.
 
 Purdue has held discussions to resolve the litigation with 
			plaintiffs' lawyers, who have often compared the cases to widespread 
			lawsuits against the tobacco industry that resulted in a $246 
			billion settlement in 1998.
 
 (Reporting by Nate Raymond in Boston; Editing by Muralikumar 
			Anantharaman)
 
			[© 2019 Thomson Reuters. All rights 
				reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. 
			
			
			 |